Regeneron Pharmaceuticals Inc. (REGN) Social Stream



Regeneron Pharmaceuticals Inc. (REGN): $684.63

-6.25 (-0.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add REGN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 393

in industry

Regeneron Pharmaceuticals Inc (REGN) Price Targets From Analysts

Use the tables below to see what analysts covering Regeneron Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 16 $850 $565 $683.266 $698.41 -2.17%
2021-11-10 16 $850 $565 $687.266 $698.41 -1.6%
2021-11-19 16 $850 $565 $697.266 $698.41 -0.16%
2021-12-07 16 $850 $570 $701.266 $698.41 0.41%
2021-12-09 17 $850 $570 $704.312 $698.41 0.85%
2021-12-28 18 $850 $570 $701.705 $698.41 0.47%
2022-01-03 18 $850 $570 $705.812 $698.41 1.06%
2022-01-04 18 $850 $570 $705.812 $698.41 1.06%
2022-01-05 18 $850 $570 $699.562 $698.41 0.16%
2022-01-10 15 $844 $575 $706.846 $698.41 1.21%
2022-01-21 15 $844 $575 $704.384 $698.41 0.86%
2022-01-28 14 $844 $575 $704.384 $698.41 0.86%
2022-02-07 14 $843 $575 $704.153 $698.41 0.82%
2022-03-21 13 $843 $575 $696.416 $698.41 -0.29%

The Trend in the Analyst Price Target


Over the past 77 days, REGN's average price target has gone down $4.5.

REGN reports an average of 11.92% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-26 24 814 460 629.73 550.55 14.38%
2021-07-24 25 828 460 641.17 586.35 9.35%
2021-08-01 25 828 460 642.30 574.61 11.78%
2021-08-14 26 906 545 674.61 624.79 7.97%
2021-08-28 25 906 545 681.75 663.29 2.78%

REGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 7 0 5 0 0 13

The Trend in the Broker Recommendations


REGN's average broker recommendation rating worsened by 0.05 over the prior 120 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Regeneron Pharmaceuticals Inc's average analyst price target is greater than 1780.6% of all US stocks.
  • In the context of Pharmaceutical Products stocks, Regeneron Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 62.16% of them.
  • In the context of Pharmaceutical Products stocks, Regeneron Pharmaceuticals Inc's number of analysts covering the stock is greater than 1682.8% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Regeneron Pharmaceuticals Inc's variance in analysts' estimates is lower than -482.39% of them.

Stocks similar to Regeneron Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RDY, RARE, and PRGO.

Is REGN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4465 seconds.